Exploring triazole-based drugs: Synthesis, application, FDA approvals, and clinical trial updates–A comprehensive review

References

Page 1

	Year	Citations
Maraviroc (UK-427,857), a Potent, Orally Bioavailable, and Selective Small-Molecule Inhibitor of Chemokine Receptor CCR5 with Broad-Spectrum Anti-Human Immunodeficiency Virus Type 1 Activity Patrick Dorr, Mike Westby, Susan Dobbs, Antimicrobial Agents and Chemotherapy Standard DeviationsImmunologyPharmacotherapyChemokine Receptor Ccr5Antiviral Drug	2005	1.1K
Maraviroc for Previously Treated Patients with R5 HIV-1 Infection Roy M. Gulick, Jacob Lalezari, James Goodrich, New England Journal of Medicine	2008	735
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with beta-thalassemia Maria Domenica Cappellini Blood	2005	713
Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update Harold J. Burstein, Christina Lacchetti, Holly Anderson, Journal of Clinical Oncology	2018	610
A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics Megan Whitnall, Jonathan Howard, Prem Ponka, Proceedings of the National Academy of Sciences Chemoprevention StrategyPathologyWide SpectrumTumor BiologyMedicinal Chemistry	2006	507
Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial David Michelson, Ellen Snyder, Erin M. Paradis, The Lancet Neurology Sleep MedicineSleep1-Year TreatmentPlacebo-controlled TrialPharmacotherapy	2014	503
Discovery of the Dual Orexin Receptor Antagonist [(7<i>R</i>)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2<i>H</i>-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia Christopher D. Cox, Michael J. Breslin, David B. Whitman, Journal of Medicinal Chemistry Psychotropic MedicationPharmacotherapyPrimary InsomniaMolecular PharmacologyMedicinal Chemistry	2010	367
Highly Efficient Asymmetric Synthesis of Sitagliptin Karl B. Hansen, Yi Hsiao, Feng Xu, Journal of the American Chemical Society	2009	304
Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials W. Joseph Herring, Kathryn M. Connor, Neely Ivgy-May, Biological Psychiatry Sleep DisordersSleepSleep DisorderPsychiatryPharmacotherapy	2014	284
A randomised comparison of deferasirox<i>versus</i>deferoxamine for the treatment of transfusional iron overload in sickle cell disease Elliott Vichinsky, Onyinye Onyekwere, John B. Porter, British Journal of Haematology	2006	270

Page 1